<code id='B8228F2612'></code><style id='B8228F2612'></style>
    • <acronym id='B8228F2612'></acronym>
      <center id='B8228F2612'><center id='B8228F2612'><tfoot id='B8228F2612'></tfoot></center><abbr id='B8228F2612'><dir id='B8228F2612'><tfoot id='B8228F2612'></tfoot><noframes id='B8228F2612'>

    • <optgroup id='B8228F2612'><strike id='B8228F2612'><sup id='B8228F2612'></sup></strike><code id='B8228F2612'></code></optgroup>
        1. <b id='B8228F2612'><label id='B8228F2612'><select id='B8228F2612'><dt id='B8228F2612'><span id='B8228F2612'></span></dt></select></label></b><u id='B8228F2612'></u>
          <i id='B8228F2612'><strike id='B8228F2612'><tt id='B8228F2612'><pre id='B8228F2612'></pre></tt></strike></i>

          focus

          focus

          author:explore    Page View:294
          Business standing in the middle of a maze near a bag with a dollar sign on it. -- biotech coverage from STAT
          Adobe

          Over the last year or two, something curious has started occurring in the conference rooms and private Zoom meetings of biotech venture capitalists.

          Representatives from pension funds, college endowments, family offices, and other organizations with money to invest have become bolder in their requests, according to interviews with a host of VCs. They’re pushing not only for advantageous terms in a VC firm’s latest fund, but in some cases, have angled for equity in the firm itself. These types of conditions aren’t unheard of, but have become more frequent as venture capitalists have a harder time raising funds, and as outside investors feel empowered to ask for more bang for their buck.

          advertisement

          “A lot is changing in venture fundraising right now,” said Nan Li, co-founder and managing partner of Dimension, which launched last January. Outside investors tried to ask for a piece of Dimension, but the new firm had more than enough interest in its first fund and was able to turn down those proposals. Two other young VC firms told STAT they’ve fielded similar requests, and one investment group reported that it had managed to negotiate an equity stake in a VC firm.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more
          AstraZeneca bets AAV gene therapy will still deliver the goods
          AstraZeneca bets AAV gene therapy will still deliver the goods

          AlastairGrant/APSengChenghasbeenworkingingenetherapyfornearlyaslongasgenetherapyhasbeenafield.Asayou

          read more
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

          AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

          read more

          How to make Best Hospitals ratings actually useful for patients

          AdobeU.S.News&WorldReport recentlyissuedits2023-24BestHospitalsratings.Theratingscomeatatimeofin